The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determinants of overall survival (OS) of primary plasma cell leukemia (pPCL): A National Cancer Database (NCDB) analysis of years 2004 to 2009.
 
Kevin Scott Landau
No Relationships to Disclose
 
Kelsey Lynn Mowery
No Relationships to Disclose
 
Hong Liang
No Relationships to Disclose
 
Chieh Lin Fu
No Relationships to Disclose
 
Chakra Pani Chaulagain
Consulting or Advisory Role - Genzyme; Janssen Biotech
Research Funding - Janssen Biotech (Inst)
Patents, Royalties, Other Intellectual Property - Janssen biotech Daratumumab patent U.S. application Ser. No. 14/629,941, filed 24 Feb. 2015, currently allowed, which claims the benefit of U.S. Provisional Application Ser. No. 61/946,002, filed 28 Feb. 2014 and U.S. Provisional Application Ser. No. 62/0